Anticonflict effects of a competitive NMDA receptor antagonist and a partial agonist at strychnine-insensitive glycine receptors

Pharmacology Biochemistry and Behavior

Volumn 54, Issue 1, 1996, Pages 73-77

  Przegalinski E ^a   Tatarczynska E ^a   Deren Wesollek A ^a   Chojnacka Wojcik E ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

1 aminocyclopropanecarboxylic acid; CGP 37849; drinking conflict test; intrahippocampal injection; peripheral administration; rats

Indexed keywords

1 AMINOCYCLOPROPANECARBOXYLIC ACID; 2 AMINO 4 METHYL 5 PHOSPHONO 3 PENTENOIC ACID; ANXIOLYTIC AGENT; GLYCINE RECEPTOR AGONIST; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PARTIAL AGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; CONFERENCE PAPER; CONFLICT; CONTROLLED STUDY; DRINKING; ELECTRIC SHOCK; HIPPOCAMPUS; HISTOLOGY; INSTRUMENTAL CONDITIONING; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOTOR DYSFUNCTION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0343549326     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/0091-3057(95)02157-4     Document Type: Conference Paper

References (46)

1. Anthony, E. W.; Nevins, M. E. Anxiolytic-like effects of N-methyl-D-aspartate-associated glycine receptor ligands in the rat potentiated startle test. Eur. J. Pharmacol. 250:317-324; 1993.
2. Beardsley, P. M.; Hayes, B. A.; Balster R. L. The self-administration of MK-801 can depend upon drug-reinforcement history, and its discriminative stimulus properties are phencyclidine-like in rhesus monkeys. J. Pharmacol. Exp. Ther. 252:953-996; 1990.
3. Bennett, D. A.; Amrick, C. L. 2-Amino-7-phosphonoheptanoic acid (AP7) produces discriminative stimuli and anticonflict effects similar to diazepam. Life Sci. 39:2455-2461; 1986.
4. Bennett, D. A.; Bernard, P.; Amrick, C. L.; Wilson, D.; Liebman, J.; Hutchison, A. Behavioral pharmacological profile of CGS 19755, a competitive antagonist at N-methyl-D-aspartate receptors. J. Pharmacol. Exp. Ther. 250:454-460; 1989.
5. Campbell, J. K.; Sherman, A. D.; Petty, F. Diazepam anxiolytic activity in hippocampus. Commun. Psychopharmacol. 4:387-392; 1980.
6. Corbett, R.; Dunn, R. W. Effects of 5,7-dichlorokynurenic acid on conflict, social interaction and plus-maze behaviors. Neuropharmacology 32:461-466; 1993.
7. 1A receptor agonists and NMDA receptor antagonists in the social interaction test and the elevated plus-maze. Eur. J. Pharmacol. 169:1-10; 1989.
8. Dunn, R. W.; Flanagan, D. M.; Martin, L. L.; Kerman, L. L.; Woods, A. T.; Camacho, F.; Wilmot, C. A.; Cornfeldt, M. L.; Effland, R. C.; Wood, P. L.; Corbett, R. Stereoselective R-(+)enantiomer of HA-966 displays anxiolytic effects in rodents. Eur. J. Pharmacol. 214:207-214; 1992.
9. Fagg, G. E.; Olpe, H.-R.; Pozza, M. F.; Baud, J.; Steinmann, M.; Schmutz, M.; Portet, C.; Baumann, P.; Thedinga, K.; Bittiger, H.; Allgeier, H.; Heckendorn, R.; Angst, C.; Brundish, D.; Dingwall, J. G. CGP 37849 and CGP 39551: Novel and potent competitive N-methyl-D-aspartate receptor antagonists with oral activity. Br. J. Pharmacol. 99:791-797; 1990.
10. Faiman, C. P.; Viu, E.; Skolnick, P.; Trullas, R. Differential effects of compounds that act at strychnine-insensitive glycine receptors in a punishment procedure. J. Pharmacol. Exp. Ther. 270:528-533; 1994.
11. Gray, J. A. Precis of the neuropsychology of anxiety: and enquiry into the functions of the septo-hippocampal system. Behav. Brain Sci. 5:469-534; 1982.
12. Guimarães, F. S.; Carobrez, A. P.; De Aguiar, J. C.; Graeff, F. G. Anxiolytic effect in the elevated plus-maze of the NMDA receptor antagonist AP7 microinjected into the dorsal periaqueductal grey. Psychopharmacology 103:91-94; 1991.
13. Herberg, L. J.; Rose, I. C. The effect of MK-801 and other antagonists of NMDA-type glutamate receptors on brain-stimulation reward. Psychopharmacology 99:87-90; 1989.
14. Izquierdo, I. Role of NMDA receptors in memory. Trends Pharmacol. Sci. 12:128-129; 1991.
15. Johnson, J. W.; Ascher, P. Glycine potentiates the NMDA responses in cultured mouse brain neurons. Nature 325:529-531; 1987.
16. 1A agonistic anxiolytic. Neuropharmacology 30:475-480; 1991.
17. Kehne, J. H.; McCloskey, T. C.; Baron, B. M.; Chi, E. M.; Harrison, B. L.; Whitten, J. P.; Palfreyman, M. G. NMDA receptor complex antagonists have potential anxiolytic effects as measured with separation-induced ultrasonic vocalizations. Eur. J. Pharmacol. 193:283-292; 1991.
18. Koek, W.; Colpaert, F. C. Selective blockade of N-methyl-D-aspartate (NMDA)-induced convulsions by NMDA antagonists and putative glycine antagonists: relationship with phencyclidine-like behavioral effects. J. Pharmacol. Exp. Ther. 252:349-357; 1990.
19. Koek, W.; Woods, J. H.; Winger, G. D. MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys. J. Pharmacol. Exp. Ther. 245: 969-974; 1988.
20. Kostowski, W.; Płaźnik, A.; Stefański, R. Intrahippocampal buspirone in animal models of anxiety. Eur. J. Pharmacol. 168: 393-396; 1989.
21. 1A receptors. J. Pharmacol. Exp. Ther. 257:1146-1153; 1991.
22. Marvizón, J. C. G.; Lewin, A. H.; Skolnick, P. 1-Aminocyclopropane carboxylic acid: a potent and selective ligand for the glycine modulatory site of the N-methyl-D-aspartate receptor complex. J. Neurochem. 52:992-994; 1989.
23. Matheus, M. G.; Nogueira, R. L.; Carobrez, A. P.; Graeff, F. G.; Guimarães, F. S. Anxiolytic effect of glycine antagonists microinjected into the dorsal periaqueductal grey. Psychopharmacology 113:565-569; 1994.
24. 3H]glutamate binding sites. Nature 306:176-179; 1983.
25. 3H]amino-5-phosphonopentanoate binding sites in rat brain. Neurosci. Lett. 52:253-258; 1984.
26. Morris, R. G.; Anderson, E.; Lynch, G. S.; Baudry, M. Selective impairment of learning and blockade of long-term potentiation by a N-methyl-D-aspartate antagonist AP5. Nature 319:774-776; 1986.
27. Nadler, V.; Kloog, Y.; Sokolovsky, M. 1-Aminocyclopropane-1-carboxylic acid (ACC) mimics the effects of glycine on the NMDA receptor ion channel. Eur. J. Pharmacol. 157:115-116; 1989.
28. Papp, M.; Moryl, E. Rewarding properties of noncompetitive and competitive NMDA antagonists as measured by place preference conditioning in rats. Pol. J. Pharmacol. 46:79-81; 1994.
29. Paxinos, G.; Watson, C. The rat brain in stereotaxic coordinates. Sydney: Academic Press; 1982.
30. Płaźnik, A.; Nazar, M.; Jessa, M. The limbic location of some central effects of competitive and noncompetitive NMDA receptor antagonist: the role in emotional control. Eur. Neuropsychopharmacol. 4:335; 1994.
31. Płaźnik, A.; Pałejko, W.; Nazar, M.; Jessa, M. Effects of antagonists at the NMDA receptor complex in two models of anxiety. Eur. Neuropsychopharmacol. 4:503-512; 1994.
32. 1A) receptors in the anticonflict activity of β-adrenoceptor antagonists. Neuropharmacology 34:1211-1217; 1995.
33. 1A receptors in the anti-conflict effect of ipsapirone. Neuropharmacology 33:1109-1115; 1994.
34. Skolnick, P.; Marvizón, J. C. G.; Jackson, B. W.; Monn, J. A.; Rice, K. C.; Lewin, A. H. Blockade of N-methyl-D-aspartate induced convulsions by 1-aminocyclopropanecarboxylates. Life Sci. 45:1647-1655; 1989.
35. 1A receptor agonists. Neuropharmacology 32:977-985; 1993.
36. Stephens, D. D.; Meldrum, B. S.; Weidmann, R.; Schneider, C.; Grutzner, M. Does the excitatory amino-acid receptor antagonist 2-APH exhibit anxiolytic activity. Psychopharmacology 90:166-169; 1986.
37. Trullas, R.; Folio, T.; Young, A.; Miller, R.; Boje, K.; Skolnick, P. 1-Aminocyclopropanecarboxylates exhibit antidepressant and anxiolytic actions in animal models. Eur. J. Pharmacol. 203:379-385; 1991.
38. Trullas, R.; Jackson, B.; Skolnick, P. Anxiolytic properties of 1-aminocyclopropanecarboxylic acid, a ligand at strychnine-insensitive glycine receptors. Pharmacol. Biochem. Behav. 34:313-316; 1989.
39. Turski, L.; Klockgether, T.; Sontag, K. H.; Herrling, P. L.; Watkins, J. C. Muscle relaxant and anticonvulsant activity of 3-((±)-2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid, a novel N-methyl-D-aspartate antagonist in rodents. Neurosci. Lett. 73:143-148; 1987.
40. Vogel, J. R.; Beer, B.; Clody, D. E. A simple and reliable conflict procedure for testing antianxiety agents. Psychopharmacologia 21:1-7; 1971.
41. Von Lubitz, D. K. J. E.; Lin, R. C.-S.; McKenzie, R. J.; Davlin, T. M.; McCabe, R. T.; Skolnick, P. A novel treatment of global cerebral ischemia with glycine partial agonist. Eur. J. Pharmacol. 219:153; 1992.
42. Watson, G. B.; Lanthorn, T. H. Pharmacological characteristics of cyclic homologues of glycine at the N-methyl-D-aspartate receptor-associated glycine site. Neuropharmacology 29:727-730; 1990.
43. Willetts, J.; Balster, R. L.; Leander, J. D. The behavioural pharmacology of NMDA receptor antagonists. Trends Pharmacol. Sci. 11:423-428; 1990.
44. Winslow, J. T.; Insel, T. R.; Trullas, R.; Skolnick, P. Rat pup isolation calls are reduced by functional antagonists of the NMDA receptor complex. Eur. J. Pharmacol. 190:11-21; 1990.
45. Xie, Z.; Commissaris, R. L. Anxiolytic-like effects of the non-competitive NMDA antagonist MK-801. Pharmacol. Biochem. Behav. 43:471-477; 1992.
46. Young, A. B.; Fagg, G. E. Excitatory amino acid receptors in the brain: membrane binding and receptor autoradiographic approaches. Trends Pharmacol. Sci. 11:126-132; 1990.